Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 107-119 , March 2010

Pharmacological agents: antifibrinolytics and desmopressin

  • Yves Ozier, MD (Professor of Anaesthesia and Critical Care)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +33 1 58 41 16 87; Fax: +33 1 58 41 14 15.
    • ,
  • Lorenn Bellamy, MD (Senior Registrar)

References 

  1. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. The New England Journal of Medicine. 2008;358:2319–2331
  2. Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006;46:327–338
  3. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. The New England Journal of Medicine. 2006;354:353–365
  4. Schneeweiss S, Seeger J, Landon J, Walker A. Aprotinin during coronary-artery bypass grafting and risk of death. The New England Journal of Medicine. 2008;358:771–783
  5. Shaw A, Stafford-Smith M, White W, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. The New England Journal of Medicine. 2008;358:784–793
  6. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;29:236–261
  7. Menichetti A, Tritapepe L, Ruvolo G, et al. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs. tranexamic acid vs. epsilon aminocaproic acid. The Journal of Cardiovascular Surgery. 1996;37:401–407
  8. Vander Salm TJ, Kaur S, Lancey RA, et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. The Journal of Thoracic and Cardiovascular Surgery. 1996;112:1098–1107
  9. Troianos CA, Sypula RW, Lucas DM, et al. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. Anesthesiology. 1999;91:430–435
  10. Kreisler KR, Vance RA, Cruzzavala J, Mahnken JD. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2005;19:608–611
  11. Greilich PE, Jessen ME, Satyanarayana N, et al. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, non-inferiority trial. Anesthesia and Analgesia. 2009;109:15–24
  12. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2007;CD001886
  13. Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115:2801–2813
  14. Eaton M. Antifibrinolytic therapy in surgery for congenital heart disease. Anesthesia and Analgesia. 2008;106:1087–1100
  15. McClure PD, Izsak J. The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology. 1974;40:604–608
  16. Rao BH, Saxena N, Chauhan S, et al. Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. The Indian Journal of Medical Research. 2000;111:57–61
  17. Chauhan S, Kumar BA, Rao BH, et al. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. The Annals of Thoracic Surgery. 2000;70:1308–1312
  18. Chauhan S, Das SN, Bisoi A, et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2004;18:141–143
  19. Williams GD, Bratton SL, Riley EC, Ramamoorthy C. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 1999;13:304–308
  20. Frederiksen MC, Bowsher DJ, Ruo TI, et al. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clinical Pharmacology and Therapeutics. 1984;35:387–393
  21. Butterworth J, James RL, Lin Y, et al. Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery. Anesthesiology. 1999;90:1624–1635
  22. Butterworth J, James RL, Lin YA, et al. Gender does not influence epsilon-aminocaproic acid concentrations in adults undergoing cardiopulmonary bypass. Anesthesia and Analgesia. 2001;92:1384–1390
  23. Ririe DG, James RL, O'Brien JJ, et al. The pharmacokinetics of epsilon-aminocaproic acid in children undergoing surgical repair of congenital heart defects. Anesthesia and Analgesia. 2002;94:44–49table of contents
  24. Bennett-Guerrero E, Sorohan J, Canada A, et al. Epsilon-aminocaproic acid plasma levels during cardiopulmonary bypass. Anesthesia and Analgesia. 1997;85:248–251
  25. Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesthesia and Analgesia. 1997;85:963–970
  26. Hardy JF, Bélisle S, Dupont C, et al. Prophylactic tranexamic acid and ε-aminocaproic acid for primary myocardial revascularization. The Annals of Thoracic Surgery. 1998;65:371–376
  27. Pleym H, Stenseth R, Wahba A, et al. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesthesia and Analgesia. 2003;96:923–928table of contents
  28. Zonis Z, Seear M, Reichert C, et al. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. The Journal of Thoracic and Cardiovascular Surgery. 1996;111:982–987
  29. Chauhan S, Bisoi A, Kumar N, et al. Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovascular & Thoracic Annals. 2004;12:121–124
  30. Bulutcu FS, Ozbek U, Polat B, et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?. Paediatric Anaesthesia. 2005;15:41–46
  31. Reid RW, Zimmerman AA, Laussen PC, et al. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesthesia and Analgesia. 1997;84:990–996
  32. Iribarren JL, Jimenez JJ, Hernandez D, et al. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene. Anesthesiology. 2008;108:596–602
  33. Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranexamic acid. Anesthesiology. 1995;82:383–392
  34. Karski JM, Dowd NP, Joiner R, et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C). Journal of Cardiothoracic and Vascular Anesthesia. 1998;12:642–646
  35. Fiechtner BK, Nuttall GA, Johnson ME, et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesthesia and Analgesia. 2001;92:1131–1136
  36. Casati V, Bellotti F, Gerli C, et al. Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesiology. 2001;94:8–14
  37. Dowd NP, Karski JM, Cheng DC, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 2002;97:390–399
  38. Nuttall GA, Gutierrez MC, Dewey JD, et al. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2008;22:230–235
  39. Rosencher N, Kerkkamp H, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43:459–469
  40. Harley BJ, Beaupre LA, Jones CA, et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Canadian Journal of Surgery. 2002;45:185–190
  41. Ray M, Hatcher S, Whitehouse SL, et al. Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty–a prospective randomized double-blind placebo-controlled study. Journal of Thrombosis and Haemostasis. 2005;3:1421–1427
  42. Camarasa MA, Olle G, Serra-Prat M, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. British Journal of Anaesthesia. 2006;96:576–582
  43. Kagoma YK, Crowther MA, Douketis J, et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thrombosis Research. 2009;123:687–696
  44. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. The Journal of Bone and Joint Surgery. British Volume. 1996;78:434–440
  45. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesthesia and Analgesia. 1997;84:839–844
  46. Jansen AJ, Andreica S, Claeys M, et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. British Journal of Anaesthesia. 1999;83:596–601
  47. Veien M, Sorensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intra-operatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiologica Scandinavica. 2002;46:1206–1211
  48. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. British Journal of Anaesthesia. 2003;90:596–599
  49. Zohar E, Ellis M, Ifrach N, et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesthesia and Analgesia. 2004;99:1679–1683table of contents
  50. Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005;45:1302–1307
  51. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology. 2006;105:1034–1046
  52. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthopaedica Scandinavica. 2001;72:442–448
  53. Lemay E, Guay J, Cote C, Roy A. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Canadian Journal of Anaesthesia. 2004;51:31–37
  54. Florentino-Pineda I, Thompson G, Poe-Kochert C, et al. The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. Spine. 2004;29:233–238
  55. Neilipovitz DT, Murto K, Hall L, et al. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesthesia and Analgesia. 2001;93:82–87
  56. Sethna NF, Zurakowski D, Brustowicz RM, et al. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102:727–732
  57. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database of Systematic Reviews. 2008;CD006883
  58. Wong J, El Beheiry H, Rampersaud YR, et al. Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesthesia and Analgesia. 2008;107:1479–1486
  59. Kang YG, Lewis JH, Navalgund A, et al. Epsilon-amino-caproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology. 1987;66:766–773
  60. Dalmau A, Sabate A, Acosta F, et al. Tranexamic acid reduces red cell transfusion better than epsilon- aminocaproic acid or placebo in liver transplantation. Anesthesia and Analgesia. 2000;91:29–34
  61. Boylan JF, Klinck JR, Sandler AN, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. 1996;85:1043–1048
  62. Kaspar M, Ramsay MAE, Nguyen AT, et al. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesthesia and Analgesia. 1997;85:281–285
  63. Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. American Journal of Transplantation. 2007;7:185–194
  64. Dalmau A, Sabate A, Koo M, et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transplantation. 2004;10:279–284
  65. Ickx BE, van der Linden PJ, Melot C, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion. 2006;46:595–605
  66. Wu C, Ho W, Cheng S, et al. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy. Annals of Surgery. 2006;243:173–180
  67. Rannikko A, Petas A, Taari K. Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology. 2004;64:955–958
  68. Choi WS, Irwin MG, Samman N. The effect of tranexamic acid on blood loss during orthognathic surgery: a randomized controlled trial. Journal of Oral and Maxillofacial Surgery. 2009;67:125–133
  69. Coats T, Roberts I, Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database of Systematic Reviews. 2004;CD004896
  70. Spahn DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline. Critical Care. 2007;11:R17
  71. Warnaar N, Molenaar IQ, Colquhoun SD, et al. Intra-operative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. Journal of Thrombosis and Haemostasis. 2007;6:297–302
  72. Martin K, Wiesner G, Breuer T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesthesia and Analgesia. 2008;107:1783–1790
  73. Breuer T, Martin K, Wilhelm M, et al. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2009;35:167–171author reply 171
  74. Stafford-Smith M, Phillips-Bute B, Reddan DN, et al. The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients. Anesthesia and Analgesia. 2000;91:1085–1090
  75. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). Journal of Thrombosis and Haemostasis. 2003;1:682–689
  76. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. The New England Journal of Medicine. 1986;314:1402–1406
  77. Hackmann T, Gascoyne RD, Naiman SC, et al. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. The New England Journal of Medicine. 1989;321:1437–1443
  78. Guay J, Reinberg C, Poitras B, et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia. 1992;75:405–410
  79. Theroux MC, Corddry DH, Tietz AE, et al. A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis:A randomized, controlled, double-blinded study. Anesthesiology. 1997;87:260–267
  80. Wong AY, Irwin MG, Hui TW, et al. Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia. 2003;50:14–20
  81. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analysis using perioperative blood transfusion as the outcome. Anesthesia and Analgesia. 1997;85:1258–1267
  82. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 1999;354:1940–1947
  83. Carless PA, Henry DA, Moxey AJ, et al. Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2004;CD001884
  84. Crescenzi G, Landoni G, Biondi-Zoccai G, et al. Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. Anesthesiology. 2008;109:1063–1076
  85. Despotis GJ, Levine V, Saleem R, et al. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet. 1999;354:106–110
  86. Reiter RA, Mayr F, Blazicek H, et al. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood. 2003;102:4594–4599
  87. Gratz I, Koehler J, Olsen D, et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. The Journal of Thoracic and Cardiovascular Surgery. 1992;104:1417–1422
  88. Dilthey G, Dietrich W, Spannagl M, Richter JA. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia. 1993;7:425–430
  89. Sheridan DP, Card RT, Pinilla JC, et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Canadian Journal of Surgery. 1994;37:33–36
  90. Pleym H, Stenseth R, Wahba A, et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia. 2004;98:578–584table of contents
  91. Ranucci M, Nano G, Pazzaglia A, et al. Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. Journal of Cardiothoracic and Vascular Anesthesia. 2007;21:851–854
  92. Jimenez-Yuste V, Prim MP, De Diego JI, et al. Otolaryngologic surgery in children with von Willebrand disease. Archives of Otolaryngology–Head & Neck Surgery. 2002;128:1365–1368

PII: S1521-6896(09)00078-0

doi: 10.1016/j.bpa.2009.09.014

Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 107-119 , March 2010

Article Tools